Slonimskaya EM - Search Results

1

Genome-wide methylotyping resolves breast cancer epigenetic heterogeneity and suggests novel therapeutic perspectives.

Tanas AS, Sigin VO, Kalinkin AI, Litviakov NV, Slonimskaya EM, Ibragimova MK, Ignatova EO, Simonova OA, Kuznetsova EB, Kekeeva TV, Larin SS, Poddubskaya EV, Trotsenko ID, Rudenko VV, Karandasheva KO, Petrova KD, Tsyganov MM, Deryusheva IV, Kazantseva PV, Doroshenko AV, Tarabanovskaya NA, Chesnokova GG, Sekacheva MI, Nemtsova MV, Izhevskaya VL, Kutsev SI, Zaletaev DV, Strelnikov VV. Tanas AS, et al. Among authors: slonimskaya em. Epigenomics. 2019 May;11(6):605-617. doi: 10.2217/epi-2018-0213. Epub 2019 Feb 7. Epigenomics. 2019. PMID: 30729807 Free article.

2

DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer.

Sigin VO, Kalinkin AI, Kuznetsova EB, Simonova OA, Chesnokova GG, Litviakov NV, Slonimskaya EM, Tsyganov MM, Ibragimova MK, Volodin IV, Vinogradov II, Vinogradov MI, Vinogradov IY, Kutsev SI, Strelnikov VV, Zaletaev DV, Tanas AS. Sigin VO, et al. Among authors: slonimskaya em. Sci Rep. 2020 Jun 8;10(1):9239. doi: 10.1038/s41598-020-66197-1. Sci Rep. 2020. PMID: 32514046 Free PMC article.

3

Genome-wide association study of loss of heterozygosity and metastasis-free survival in breast cancer patients.

Deryusheva IV, Tsyganov M, Garbukov EY, Ibragimova MK, Kzhyshkovska JG, Slonimskaya E, Cherdyntseva NV, Litviakov NV. Deryusheva IV, et al. Exp Oncol. 2017 Jul;39(2):145-150. Exp Oncol. 2017. PMID: 29483489

4

Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy.

Litviakov NV, Cherdyntseva NV, Tsyganov MM, Slonimskaya EM, Ibragimova MK, Kazantseva PV, Kzhyshkowska J, Choinzonov EL. Litviakov NV, et al. Among authors: slonimskaya em. Oncotarget. 2016 Feb 16;7(7):7829-41. doi: 10.18632/oncotarget.6953. Oncotarget. 2016. PMID: 26799285 Free PMC article.

5

Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer.

Tsyganov MM, Freidin MB, Ibragimova MK, Deryusheva IV, Kazantseva PV, Slonimskaya EM, Cherdyntseva NV, Litviakov NV. Tsyganov MM, et al. Among authors: slonimskaya em. Cancer Chemother Pharmacol. 2017 Aug;80(2):251-260. doi: 10.1007/s00280-017-3354-1. Epub 2017 Jun 10. Cancer Chemother Pharmacol. 2017. PMID: 28601971

6

Neoadjuvant Chemotherapy Induces the Appearance of New Copy Number Aberrations in Breast Tumor and is Associated with Metastasis.

Litviakov NV, Ibragimova MK, Tsyganov MM, Doroshenko AV, Garbukov EY, Slonimskaya EM. Litviakov NV, et al. Among authors: slonimskaya em. Curr Cancer Drug Targets. 2020;20(9):681-688. doi: 10.2174/1568009620666200506104523. Curr Cancer Drug Targets. 2020. PMID: 31577208

7

Amplification of Stem Genes: New Potential Metastatic Makers in Patients with an Early Form of Breast Cancer.

Tsyganov MM, Ibragimova MK, Pevzner AM, Doroshenko AV, Slonimskaya EM, Litviakov NV. Tsyganov MM, et al. Among authors: slonimskaya em. J Korean Med Sci. 2019 Dec 23;34(49):e312. doi: 10.3346/jkms.2019.34.e312. J Korean Med Sci. 2019. PMID: 31858753 Free PMC article.

8

Amplifications of Stemness Gene Loci-New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study.

Litviakov NV, Ibragimova MK, Tsyganov MM, Kazantseva PV, Doroshenko AV, Garbukov EY, Frolova IG, Slonimskaya EM. Litviakov NV, et al. Among authors: slonimskaya em. J Pers Med. 2021 May 11;11(5):397. doi: 10.3390/jpm11050397. J Pers Med. 2021. PMID: 34064798 Free PMC article.

9

Stem gene expression in breast tumors during chemotherapy: Connection with the main clinical and morphological factors and the disease outcome.

Ibragimova MK, Tsyganov MM, Deryusheva IV, Slonimskaya EM, Litviakov NV. Ibragimova MK, et al. Among authors: slonimskaya em. J Cancer Res Ther. 2022 Jan-Mar;18(1):89-95. doi: 10.4103/jcrt.JCRT_1331_20. J Cancer Res Ther. 2022. PMID: 35381768 Free article.

10

Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.

Litviakov NV, Bychkov VA, Stakheeva MN, Ibragimova MK, Tsyganov MM, Gaptulbarova KA, Tashireva LA, Bondar LN, Garbukov EY, Slonimskaya EM. Litviakov NV, et al. Among authors: slonimskaya em. J Mol Histol. 2020 Dec;51(6):717-728. doi: 10.1007/s10735-020-09917-1. Epub 2020 Oct 10. J Mol Histol. 2020. PMID: 33037978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page